BioCorRx (BICX) Share-based Compensation (2012 - 2026)
BioCorRx (BICX) posted Share-based Compensation of $351258.0 for Q4 2025, up 2087.16% sequentially from $16060.0 in Q3 2025, and up 189.32% YoY from $121408.0 in Q4 2024.
Analysis
BioCorRx (BICX) Share-based Compensation (2012 - 2026) Analysis & Trends
BioCorRx has reported Share-based Compensation for 14 years, with the latest figure at $351258.0 in Q4 2025.
- Quarterly Share-based Compensation rose 189.32% year-over-year to $351258.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $398033.0 (up 84.06% YoY) and the FY2025 annual result came in at $592604.0, up 158.1% from the prior year.
- Share-based Compensation improved to $351258.0 in Q4 2025 per BICX's latest filing, from $16060.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $351258.0 in Q4 2025 and troughed at -$172429.0 in Q4 2022.
- A 5-year average of $30148.2 and a median of $29261.0 in 2024 frame the typical range for Share-based Compensation.
- The sharpest annual moves came in 2021 and 2022: Share-based Compensation tumbled 154.5% in 2021, then soared 320.37% in 2022.
- Over 5 years, Share-based Compensation stood at -$157625.0 in 2021, then declined by 9.39% to -$172429.0 in 2022, then soared by 122.19% to $38263.0 in 2023, then jumped by 217.3% to $121408.0 in 2024, then jumped by 189.32% to $351258.0 in 2025.
- According to Business Quant data, Share-based Compensation over the past three periods registered $351258.0, $16060.0, and $30715.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | 85.00 Mn |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | -3.00 Mn |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | - |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | 659,000.00 |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | 199.20 Mn |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 38.43 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 9.05 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | 25.83 Mn |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | 4.13 Mn |
| 10 | BioCorRx | 3.46 Mn | 3.44 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.67 Mn |
| Dec 31, 2025 | 351,258.00 |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 1.53 Mn |
| Mar 31, 2025 | 151,257.00 |
| Dec 31, 2024 | 285,533.00 |
| Sep 30, 2024 | 29,261.00 |
| Jun 30, 2024 | 30,480.00 |
| Mar 31, 2024 | 935,068.00 |
| Dec 31, 2023 | 38,263.00 |
| Sep 30, 2023 | 887,901.00 |
| Jun 30, 2023 | 882,869.00 |
| Mar 31, 2023 | 882,530.00 |
| Dec 31, 2022 | 71,001.00 |
| Sep 30, 2022 | 848,559.00 |
| Jun 30, 2022 | 843,004.00 |
| Mar 31, 2022 | 831,138.00 |
| Dec 31, 2021 | 43,175.00 |
| Sep 30, 2021 | 831,138.00 |
| Jun 30, 2021 | 818,631.00 |